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Background. Placental endocrine insufficiency may increase the risk of depression and 14 
anxiety during pregnancy and/or after birth. This study investigated the association between 15 
serum human placental lactogen (hPL) and measures of perinatal mental health, accounting 16 
for selective serotonin-reuptake inhibitor (SSRI) usage.  17 
Method. Caucasian women with singleton, term pregnancies recruited at their pre-surgical 18 
appointment prior to an elective caesarean section (ELCS) were studied. Serum hPL levels in 19 
maternal blood collected at recruitment were measured by ELISA. Depression and anxiety 20 
scores were derived from Edinburgh Postnatal Depression Scale (EPDS) and the trait 21 
subscale of the State-Trait Anxiety Inventory (STAI) questionnaires completed at recruitment 22 
and three postnatal time points. Data was analysed by unadjusted and adjusted multiple linear 23 
regression. 24 
Results. In adjusted linear regressions, term maternal serum hPL levels were negatively 25 
associated with postnatal EPDS and STAI score ten weeks postnatal for mothers who had 26 
girls (B= -.367 , p= .022, 95% CI -.679, -.056; and B= -.776, p= .030, 95% CI -1.475, -.077 27 
respectively). Excluding women prescribed SSRIs strengthened the relationship at 10 weeks 28 
and uncovered an earlier association between hPL and mood scores within one week of 29 
delivery (EPDS B= -.357 , p= .041, 95% CI -.698, -.015; and STAI B= -.737, p= .027, 95% CI 30 
-1.387, -.086). In mothers who had boys, there were no associations between hPL and mood 31 
scores at any time point. 32 
Conclusion. Low hPL predicted postnatal depression and anxiety symptoms exclusively in 33 
mothers of girls. Insufficiency in hPL may contribute to maternal mood symptoms.  34 
 35 
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anxiety  37 
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1. Introduction 38 
During pregnancy, women are highly vulnerable to perinatal mental health problems, with 39 
depression and anxiety among the most common (Bauer et al., 2014) and associated with 40 
substantial morbidity to both mother and child (Stewart, 2011). Poor mental health in 41 
pregnancy is strongly linked to postnatal depression, both having negative effects on mother–42 
child interactions and child development in the short and longer term (Brand and Brennan, 43 
2009; Kinsella and Monk, 2009). A recent study in the UK estimated that maternal mental 44 
health disorders have a long-term cost to UK society of £8.1 billion for each one-year cohort 45 
of births with nearly three-quarters of this cost relating to adverse impacts on the child (Bauer 46 
et al., 2014). Despite the considerable clinical, financial and emotional burden to society, and 47 
the reporting of many risk factors, the biological mechanisms are unknown. Consequently, our 48 
ability to predict which women will experience significant mental health symptoms related to 49 
pregnancy is severely limited. 50 
Hormonal changes represent prime candidates linking pregnancy to the higher vulnerability 51 
for depression because their levels change dramatically, driven in part by the placenta acting 52 
as an endocrine organ (Burton and Fowden, 2015). The human placenta is the source of 102 53 
polypeptide hormones contributing to the co-ordinated induction and maintenance of maternal 54 
physiology and behaviour (Liu et al., 2018). Studies in rodent models directly demonstrate the 55 
importance of prolonged exposure to oestrogen, progesterone, and the lactogenic hormones 56 
prolactin and placental lactogens in the induction of maternal care behaviours (Creeth et al., 57 
2019). To date there is little direct evidence from human studies to support altered levels of a 58 
specific pregnancy hormone in perinatal depression or anxiety. However, there is indirect 59 
evidence to suggest that lactogenic signalling may be important. Human placental lactogen 60 
(hPL) is coded for by three separate genes with the majority of term hPL derived from the 61 
human chorionic somatomammotropin 1 (CSH1) gene (Männik et al., 2010). hPL is present at 62 
considerably higher levels than the pituitary hormone prolactin in the maternal serum at term 63 
(5–7 vs. 0.15–0.18 µg/ml) (Newbern and Freemark, 2011) and both hormones bind and 64 
activate the prolactin receptor (Gurtunca and Sperling, 2017). Maternal serum hPL levels and 65 
placental hPL expression have previously been demonstrated to be significantly reduced in 66 
pregnancies complicated by fetal growth restriction (Männik et al., 2010; Roh et al., 2005). We 67 
reported an association between lower maternal serum hPL and being born small for 68 
gestational age (Janssen et al., 2016b). Fetal growth restriction is more common when 69 
mothers experience prenatal depression (Diego et al., 2009). Maternal obesity has been 70 
associated with decreased placental hPL expression at term (Vakili et al., 2013) potentially as 71 
a consequence of changes in the interactions between key regulatory elements at the gene 72 
locus (Jin et al., 2018). Maternal obesity is a risk factor for maternal depression and anxiety 73 
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(Molyneaux et al., 2014). Decreased maternal serum levels of prolactin (Gurtunca and 74 
Sperling, 2017), have been reported in human mothers with postnatal depression symptoms 75 
(Groer and Morgan, 2007; Ingram et al., 2003).  Maternal serum levels of prolactin have been 76 
inversely correlated with anxiety scores during pregnancy (Asher et al., 1995). We reported 77 
lower placental hPL gene expression in term placenta from women with clinically diagnosed 78 
depression and women self-reporting clinically significant symptoms of depression (Janssen 79 
et al., 2016a). In this 2016 study, we were not able to compare depression symptoms to serum 80 
levels of hPL as either the sample numbers were too low or the data was not collected. An 81 
additional factor which may have not been considered in previous studies in the confounder 82 
of antidepressant usage in pregnancy. Selective serotonin reuptake inhibitors (SSRIs), which 83 
are commonly prescribed in pregnancy to manage mood symptoms (Dubovicky et al., 2017), 84 
have a lactogenic activity (Goodnick et al., 2005), potentially masking any relationship 85 
between placental lactogens levels and mood symptoms 86 
The aims of this study were to investigate the relationship between maternal serum levels of 87 
hPL in term pregnancies and both maternally reported symptoms of depression and anxiety. 88 
A sensitivity analyses was performed to further understand the relationship between mood 89 
symptoms and hPL levels. These analyses were performed using data from the Grown in 90 
Wales cohort (Janssen et al., 2018). 91 
2. Method 92 
2.1 Cohort 93 
Full ethical approval for the Grown in Wales (GiW) Study cohort (Janssen et al., 2018) was 94 
obtained from the Wales Research Ethics Committee REC reference 15/WA/0004. Research 95 
was carried out in line with the principles of the Declaration of the Helsinki as revised in 2008. 96 
Briefly, the GiW study is a longitudinal birth cohort based in South East Wales, United Kingdom 97 
that began in September 2015 and ended recruitment in November 2016. Women aged 98 
between 18 and 45 with a singleton term pregnancy without fetal abnormalities or infectious 99 
diseases were recruited at their morning pre-surgical appointment prior to an elective 100 
caesarean section (ELCS) at the University Hospital of Wales by two trained research 101 
midwives.  102 
2.2 Participant numbers 103 
355 women were recruited into the study and seven withdrew. hPL concentrations were 104 
available for 272 of these women of whom 251 had fully complete antenatal self-reported 105 
mental health data at term. However not all of the participants completed mental health 106 
questionnaires at all time points (Supplementary Table 2). 91% of participants in the Grown in 107 
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Wales cohort reported Caucasian ethnicity (Janssen et al., 2018), and the current study 108 
focused on this group of 233 women.  109 
2.3 Materials 110 
2.3.1 Maternal depression and anxiety symptoms 111 
Maternal mental health was measured through two self-reporting questionnaires, both 112 
validated for pre- and post-natal use. Depression was measured using the Edinburgh 113 
Postnatal Depression Scale (EPDS) which comprises of ten questions each scored between 114 
zero and three, with total scores 13 and above indicating probable depression (Cox et al., 115 
1987; Matthey et al., 2006). Anxiety was measured using the Trait subscale of the State Trait 116 
Anxiety Index to measure general anxiety levels (Meades and Ayers, 2011; Spielberger et al., 117 
1983). This subscale contains 20 questions scored between one and four, with final scores of 118 
40 and above indicating high anxiety levels. Both questionnaires were filled in at the pre-119 
surgical appointment (A1), within seven days of birth (P1), ten weeks (P2) and 12 months 120 
postnatally (Y1). Missing data was addressed using participant level mean substitution for 121 
those missing <20% of data. 122 
2.3.2 Selective Serotonin Re-uptake Inhibitor (SSRI) use 123 
SSRI prescription records were recorded by research midwives from the medical notes after 124 
birth. 125 
2.3.3 Human placental lactogen 126 
Maternal venous serum samples were obtained at recruitment from blood taken as part of an 127 
anaesthetic review. Serum was obtained by centrifugation of maternal venous blood which 128 
was then frozen at −80°C. hPL levels were assayed in duplicate using the Leinco 129 
Technologies Human Placental Lactogen (HPL) Micro-ELISA test kit (Universal Biologicals 130 
product code T115-96 tests). Assays were performed by the NIHR Cambridge Biomedical 131 
Research Centre, Core Biochemical Assay Laboratory. 132 
2.3.4 Maternal demographics and birth outcomes 133 
Maternal lifestyle and demographics were reported by the mother in the questionnaire at 134 
recruitment. Data included ethnicity, education, income, age, and whether they smoked or 135 
drank alcohol during their pregnancy. Welsh Index of Multiple Deprivation (WIMD) 2014 scores 136 
were calculated from anonymised postcodes (http://wimd.wales.gov.uk). Delivery information, 137 
fetal and placental biometry, body mass index at initial booking and parity were taken from the 138 
research midwifes notes after birth.  139 
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2.4 Statistical analysis 140 
All statistical tests were carried out in IBM SPSS Statistics Version 23. Normality was 141 
assessed using Shapiro-Wilk test, Kolmogorov-Smirnov test, histograms and normal Q-Q 142 
plots. EPDS, STAI scores and hPL concentration were all found to be not normally distributed, 143 
and therefore non-parametric tests were used going forward. Chi squared tests and 144 
Spearman’s correlations were used when analysing demographic data for categorical and 145 
continuous data respectively. Both unadjusted and adjusted linear regression was used to 146 
assess the relationship between hPL and maternal perinatal mental health. Potential 147 
confounders that had a significant relationship with A1 EPDS or A1 STAI through univariate 148 
linear regressions were taken forward to a multiple linear regression with either A1 EPDS or 149 
STAI. Due to the large number of potential confounding variables, backward selection was 150 
then used to choose the final variables to include. To simplify analyses, those that were 151 
significant in either A1 EPDS or A1 STAI were taken forward to all the subsequent adjusted 152 
linear regressions to ensure the same confounders were used throughout all analysis. A 153 
sensitivity analysis was performed to determine the effect of SSRI usage during pregnancy on 154 
hPL levels. Women that were prescribed SSRIs at any point during their pregnancy were 155 
removed from the dataset and the unadjusted and adjusted multiple linear regressions were 156 
performed again. All unadjusted and adjusted linear regressions were run separately for 157 
participants who had girls and boys. Figure was created in R Studio Version 1.1.463. 158 
 159 
3. Results 160 
Demographics of the 233 women in this study are provided in Table 1. The relationship 161 
between these variables and maternal hPL levels are described, by either chi-squared or 162 
Spearman’s correlation tests for categorical and continuous data respectively (Table 1). 163 
Serum hPL levels were significantly associated with birth weight as previously reported 164 
(Männik et al., 2010; Roh et al., 2005), head circumference and placental weight. Two 165 
maternal characteristics associated with serum hPL were maternal BMI, as reported in other 166 
studies (Vakili et al., 2013), and WIMD score. WIMD is designed to identify the small areas of 167 
Wales that are the most deprived related to multiple indicators including income, employment 168 
status, health status and educational achievement. Higher scores are associated with an 169 
increased percentage of people being treated for mental health conditions 170 
(http://wimd.wales.gov.uk). However, individually mental health history, education or income 171 
were not associated with serum hPL.  172 
A1 EPDS and STAI scores recorded just prior to the term delivery were strongly associated 173 
with depression/anxiety scores recorded at all three postnatal time points (p > 0.001 for all 174 
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comparisons; Supplementary Table 1). Prenatal mood scores were chosen to decide the 175 
confounding variables for testing. Maternal depression and anxiety scores were recorded at 176 
four time points. Not all of women completed all four questionnaires, with completion rate 177 
lowest at Y1 (Supplementary Table 2). The relationships between both mood scores and 178 
potential confounders were assessed using univariate linear regressions (Supplementary 179 
Table 3). Those that were significant at the p<.05 level were taken forward to a multiple linear 180 
regression analysis with EPDS and STAI independently. A backward selection process was 181 
performed to choose the final confounders to enter into the adjusted model. The confounders 182 
significant with A1 EPDS at p<0.05 were ‘history of mental health’ and ‘highest education 183 
level’. The potential confounders significant with A1 STAI at p<0.05 were ‘history of mental 184 
health’ and ‘WIMD’. All three factors were taken forward into the adjusted linear regressions. 185 
To investigate the relationship between hPL and perinatal anxiety and depression, multiple 186 
linear regression was used. Unadjusted, there was no significant associations when all 187 
participants were included (Table 2). However, when splitting analyses by fetal sex, term 188 
anxiety scores (p=.041) and both ten week depression (p=.037) and anxiety scores (p=.047) 189 
were significantly associated with hPL concentration when the infant was a girl but not when 190 
the infant was a boy (Table 2). After adjustment for the three confounders, the relationship 191 
between hPL and depression and anxiety scores at ten weeks postnatal for mothers of girls 192 
remained significantly negatively associated (EPDS p=.022 and STAI p=.030) (Table 2). After 193 
controlling for a history of mental health, WIMD and highest education level, hPL 194 
concentrations predicted a decrease in depression scores (B= -.367) and more strongly in 195 
anxiety (B= -.776) in women with girls.  196 
To determine if there were an effect of SSRI usage on the relationship between hPL and 197 
maternal mental health, a sensitivity analysis was performed. Those who were prescribed 198 
SSRIs at any point during their pregnancy were removed from the analyses and the linear 199 
regressions repeated. There were 21 women prescribed SSRIs, 13 of which had boys and 200 
eight who had girls. The unadjusted linear regressions uncovered a significant association 201 
between hPL concentrations at three time points: just prior to delivery (A1), within one week 202 
of delivery (P1) and 10 weeks after delivery (P2) for both depression and anxiety when the 203 
infant was female (Table 3; Figure 1). After adjustment for the three confounders, the 204 
relationship between hPL and depression and anxiety scores at one week and ten weeks 205 
postnatal remained significantly negatively associated (Table 3). Again, this was only 206 
significant for mothers of girls and not mothers of boys. hPL predicted a larger decrease in 207 
depression scores at P2 compared to P1 (B= -.357 and B= -.737 respectively), and the reverse 208 
was true of anxiety scores (B= -.718 and B= -.337, respectively). Sex-specific association was 209 
not related to inherent, naturally occurring differences in the levels of hPL between mothers 210 
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pregnant with male versus female infants (EPDS <13; male infant/without SSRIs 8.33 ± .3 211 
versus female infant/without SSRIs 8.58 ± .3 female; p=.533). 212 
 213 
4. Discussion 214 
Here we report that lower levels of maternal serum human placental lactogen (hPL) measured 215 
at term are predictive of higher maternal depression and anxiety scores postnatally, but only 216 
in women who gave birth to girls. This negative association was initially only significant for 217 
mood scores reported ten weeks after delivery. However, removing data from participants 218 
prescribed SSRIs during their pregnancy strengthened the results and additionally predicted 219 
mood scores within one week of the birth. For mothers of boys, there were no association 220 
between maternally reported symptoms of depression or anxiety with hPL.  221 
This is the first study to report a sex-specific relationship between serum human placental 222 
lactogen levels and postnatal depression and anxiety symptoms. Although the unit of change 223 
was small, hPL concentrations were significantly negatively associated with postnatal 224 
depression and anxiety. Furthermore, this association was only present for women who had 225 
girls. We previously reported an association between lower expression of the hPL gene in the 226 
placenta of women with prenatal symptoms of depression (Janssen et al., 2016a) highlighting 227 
the same inverse relationship in two independent studies. Considerable experimental data 228 
exists to demonstrate that lactogenic hormones, both prolactin and placental lactogen, are 229 
important for the appropriate induction of maternal behaviour in rodents. In particular, infusion 230 
of placental lactogen into the brain of virgin female rodents causes them to adopt maternal 231 
behaviours  whereas blocking lactogenic signalling by ablating the prolactin receptor, to which 232 
the hormone binds, results in a lack of pup-induced maternal behaviour and altered indicating 233 
a key contribution of lactogenic signalling to maternal behaviour and changes in the brain 234 
(Creeth et al., 2019). In vivo, placental lactogens are proposed to enter the maternal brain 235 
through the choroid plexus, which accumulates the short and long isoforms of the prolactin 236 
receptor to facilitate their entry into the brain (Augustine et al., 2003; Bridges and Hays, 2005; 237 
Grattan, 2002; Pi et al., 2003). Placental lactogens are thought to bind the prolactin receptor 238 
in the medial preoptic area (MPOA) and paraventricular nucleus (PVN) of the hypothalamus 239 
and the hippocampus (Bridges et al., 1990; Brown et al., 2017; Kokay et al., 2006; Torner et 240 
al., 2009; Vergara-Castañeda et al., 2016),  regions important for maternal behaviour (Kimble 241 
et al., 1967; Stack et al., 2002). We have experimentally demonstrated, again in rodents, that 242 
altering the endocrine function of the mouse placenta alters maternal caregiving behaviour 243 
(Creeth et al., 2018) and that a smaller endocrine compartment is associated with higher levels 244 
of maternal anxiety (McNamara et al., 2018). These data suggest a causal relationship 245 
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between lower levels of hPL and the development of symptoms of depression and anxiety in 246 
human pregnancy because women do not undergo the appropriate brain adaptations required 247 
to initiate maternal behaviour.  248 
A second important finding of this study was that removing data from women prescribed SSRIs 249 
in pregnancy strengthened the relationship between mood symptoms and hPL levels. SSRIs 250 
function by selectively binding the 5-hydroxytryptamine transporter blocking the reuptake of 251 
serotonin by pre-synaptic neurons resulting in enhanced serotonergic function in the brain 252 
(Sangkuhl et al., 2009). Serotonin induces the release of prolactin-releasing factors from the 253 
hypothalamus stimulating the pituitary to release prolactin causing prolactinaemia, at least in 254 
rodents (Gil-ad et al., 1976; Kamberi et al., 1971). Although human literature is conflicting, a 255 
large pharmacoepidemiological study reported a clear association between SSRIs and a rise 256 
in serum prolactin (Petit et al., 2003). If SSRI usage is associated with prolactinaemia in 257 
pregnancy, this could explain why removing data from women prescribed SSRIs strengthened 258 
the association between mood symptoms and hPL levels.  Together, these data suggest a 259 
mechanism through which placental endocrine dysfunction could increase the risk of 260 
depression in mothers both during pregnancy and immediately after birth and also suggest a 261 
mechanism through which SSRIs might function to alleviate maternal symptoms. 262 
In this study we observed a sex-specific association between serum placental lactogens and 263 
postnatal mood symptoms. Although some placental hormones show inherent sex differences, 264 
such as human chorionic gonadotropin which is higher when the fetus is female (Adibi et al., 265 
2015), we did not find significant sex-differences in the level of hPL. Lower maternal serum 266 
levels of hPL have been reported in small for gestational age pregnancies, but only when the 267 
infant was female (Lagerström et al., 1990). Similarly, maternal smoking has been associated 268 
with lower maternal hPL in mothers carrying girls but not boys (Bremme et al., 1990). These 269 
relationships may reflect sex-specific endocrine responses by the male and female placenta. 270 
4.1 Limitations 271 
Both a strength and a limitation of our study is the defined nature of the cohort. Grown in Wales 272 
is set in South Wales where the majority of the population are Caucasian. We examined data 273 
exclusively from Caucasian women to avoid confounders that can be introduced by ethnic 274 
differences (Bornstein et al., 2013; Capron et al., 2018). We had too few women in our study 275 
representing distinct other ethnicities. All women in the cohort were recruited at a single site 276 
by the same two highly trained research midwives where they completed the EPDS and STAI 277 
questionnaires, and where blood was collected in advance of their planned surgery. Therefore, 278 
all women were in the same environment when responding to questionnaires and providing 279 
blood samples, and anticipating a surgical delivery. The homogenous nature of the cohort 280 
 
 10 
provided a clear advantage uncovering the reported associations with relatively small numbers 281 
of participants. However, our findings may not apply to other ethnicities or to other modes of 282 
delivery. It will therefore be important to replicate these findings in more diverse cohorts, and 283 
across other modes of delivery. A second limitation of this study are the smaller sample sizes 284 
at the later time points (P2=124, Y1=95). The negative associations between hPL and mood 285 
were only significant in women with girls and there were higher numbers for this group at each 286 
time point. With more samples from boys, a similar association between low hPL and maternal 287 
mood symptoms may be present where the fetus is male. A third limitation is that serum hPL 288 
was measured at a single time point. We do not know whether low hPL is present at earlier 289 
time points. This knowledge has important implications for the use of hPL levels as a predictive 290 
biomarker.  291 
5. Conclusions 292 
This study set out to assess the relationship between maternal hPL concentrations at term 293 
and perinatal mental health measures in the Grown in Wales Study cohort. hPL serum levels 294 
at term were found to predict postnatal depression and anxiety scores. The inverse 295 
relationships between low hPL and high scores for depression and anxiety were significant for 296 
mothers who had girls, and not those who had boys. Excluding those prescribed SSRIs during 297 
pregnancy strengthened the relationship. Our data is consistent with the hypothesis that low 298 
lactogenic signalling contributes to perinatal mood disorders rescued, in part, by the 299 
prolactinaemic function of SSRIs. 300 
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Table 1. Demographic and birth data for 233 participants and relationship with maternal 452 
hPL 453 
Demographics % (n) or median (IQR) p 
Maternal age 33 (7) .348 
Parity 1 (1) .109 
Maternal BMI at booking 26.4 (7.3) .009** 
WIMD score a 1270 (1200) .002** 
History of mental health, % (n) 
   No 





SSRI use in pregnancy, % (n) 
   No 





SSRI use at term, % (n) 
   No 





Highest education level, % (n) 
   Left before GCSE 
   GCSE or vocational 
   A-level 
   University 
   Postgraduate 









Family income, % (n) 
   <£18,000 
   £18-25,000 
   £25-43,000 
   >£43,000 








Smoking in pregnancy b, % (n) 
   No 





Alcohol in pregnancy c, % (n) 
   No 
   Yes 






Season of birth, % (n) 
   Spring 
   Summer 
   Autumn 







Fetal sex, % (n) 
   Female 





Gestational age (days) 274 (3) .238 
Placental weight (g) 654 (171) <.001*** 
Birth weight (g) 3500 (665) <.001*** 
Head circumference (cm) 35.5 (2.2) .002** 
Categorical data compared with hPL using chi squared tests, and continuous data with 454 
Pearson’s correlations. BMI (Body Mass Index), WIMD (Welsh Index of Multiple Deprivation), 455 
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SSRI (Selective Serotonin Reuptake Inhibitors). Data is for 233 participants with the exception 456 
of head circumference (n=231) and placental weight (n=228), WIMD (n=227) and BMI 457 
(n=222). 458 
a WIMD scores range from 1-1909 with higher scores indicating a small area of a lower overall 459 
deprivation, and a low score indicative of higher overall deprivation. 460 
b At any point in pregnancy 461 
c Weekly at any point in pregnancy 462 
 463 
Table 2. Unadjusted and adjusted multiple linear regression models analysing 464 
association between hPL concentration µg/ml and maternal mental health scores. 465 
Mood 
scores 
All Male Female 
B 95% CI p B 95% CI p B 95% CI p 





























.233 .005 -.409, 
.419 










































































A1 STAI .012 -.385, 
.409 





















































Y1 EPDS .077 -.269, 
.423 


















A1 (at term pre-surgical appointment), P1 (up to seven days postnatally), P2 (ten weeks 466 
postnatally), Y1 (12 months postnatally), EPDS (Edinburgh Postnatal Depression Scale), STAI 467 
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(Speilberger State Trait Anxiety-Trait subscale). Adjusting for history of mental health, WIMD, 468 
and Highest education level. 469 
 470 
 471 
Table 3. Unadjusted linear regression assessing relationship between hPL and 472 
perinatal mental health scores, in women not prescribed SSRIs. 473 
Mood 
scores 
All Male Female 
B 95% CI p B 95% CI p B 95% CI p 






































































































































































Y1 EPDS .065 -.280, 
.411 


















Adjusted for history of mental health, WIMD, and Highest education level. 474 
 475 
 476 
  477 
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Figure legends 478 
Figure 1: Maternal serum hPL values correlate with EPDS and STAI scores for mothers 479 
of girls 480 
Spearman’s correlation of maternal serum hPL levels measured just prior to a term ELCS 481 
delivery and perinatal mental health scores in women not prescribed SSRIs analysing male 482 
and female data separately. Line of best fit is linear model. A1: at pre-surgical appointed prior 483 








Male: p= 0.822, r=0.031
Female: p=0.020*, r=-0.282
Male: p=0.427, r=-0.110











Supplementary Tables 487 
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 (Correlation coefficient; p value) 490 
A1 (at pre-surgical appointment), P1 (up to seven days postnatally), P2 (ten weeks 491 
postnatally), Y1 (12 months postnatally), EPDS (Edinburgh Postnatal Depression Scale), STAI 492 
(Speilberger State Trait Anxiety-Trait subscale). 493 
 494 
Supplementary Table 2: Numbers of participants at each time point 495 
 All Male Female 
A1 EPDS 233 106 127 
A1 STAI 233 106 127 
P1 EPDS 133 62 71 
P1 STAI 135 62 73 
P2 EPDS 124 56 68 
P2 STAI 122 54 68 
Y1 EPDS 95 36 59 
Y1 STAI  96 36 60 
 496 
 497 
Supplementary Table 3: Univariate linear regression p values of potential confounders with 498 
antenatal mental health.  499 
Demographics A1 EPDS p value A1 STAI p value 
Maternal age .347 .476 
Parity .996 .557 
Maternal BMI at booking .139 .265 
WIMD score a .029* .004** 
Highest education level 







   GCSE or vocational 
   A-level 
   University 










   <£18,000 
   £18-25,000 
   £25-43,000 











Smoking in pregnancy b .025* .040* 
Alcohol in pregnancy c .073 .069 
Gestational age (days) .692 .844 
History of mental health >.001*** >.001*** 
Ref. (reference category) 500 
a WIMD score ranges from 1-1909, high score indicating a small area of a lower overall 501 
deprivation, and a low score of higher overall deprivation. 502 
b At any point in pregnancy 503 
c Weekly at any point in pregnancy 504 
 505 
 506 
